The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions
FUTURE ONCOLOGY(2024)
关键词
eNRGy trial,HER2,HER3,NRG1+,NRG1 fusion,NSCLC,PDAC,recruiting,Zeno,Zenocutuzumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要